Home » Newsletters » BioWorld Science

BioWorld Science

May 4, 2015

View Archived Issues

Anti-GDF-15 MAb restores CACS-associated phenotypic and metabolic changes

First preclinical results presented for a novel HER2-targeted ADC

Researchers report development of second-generation BTK inhibitors

Hamni Pharmaceutical divulges preclinical data of HM-95573

Pharmacokinetic assessments of RG-101 in healthy volunteers and HCV patients

GSK-2330672 as a treatment for pruritus associated with primary biliary cirrhosis

Bristol-Myers Squibb offers overview of first quarter 2015

Arena discloses results from phase I trial of APD-371

NIH grants supports SomaGenics' development of NGS microRNA library technology

Spark Therapeutics gains option to license microinjector technology

CRISPR Therapeutics raises USD 64 million in Series A and B financings

Arno's AR-12 receives E.U. orphan drug status for cryptococcosis and tularemia

Epigenomics receives E.U. grant to fund development of lung cancer blood test

Polish university discloses AdFU derivatives

Washington University patent describes Abeta imaging compounds

Agios to advance third IDH mutant inhibitor AG-881 into clinical development

Infinity Pharmaceuticals reports development of PI3K inhibitors

Merck & Co. patents cathepsin K inhibitors

Aequus and Corium collaborate on transdermal products for neurological disorders

Nihon Pharmaceutical divulges adipose tissue-derived MSCs

FDA approves Raplixa powdered fibrin sealant to help control surgical bleeding

FDA clears RE-024 for clinical study

Breo Ellipta approved in the U.S. for treating asthma in adults

Acceleron and Celgene to advance luspatercept into phase III for anemia and beta-thalassemia

FDA approves Ionsys for management of acute postoperative pain

Ixinity gains first approval for hemophilia B

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for April 20, 2026.
Biohaven reports details on discovery of BHV-2100
BioWorld Science
Transient receptor potential melastatin 3 (TRPM3) is a calcium-permeable TRP channel that is highly expressed in somatosensory neurons, including nociceptors of...
Meta-analysis: Anti-amyloid Alzheimer’s drugs not ‘clinically meaningful’
BioWorld
The ongoing controversy over the effectiveness of anti-amyloid drugs is about to get more heated, after a review of clinical trials showed statistically...
New GABA(B) receptor PAMs revealed in Addex Pharma patents
BioWorld Science
Addex Pharma SA has disclosed new GABA(B) receptor positive allosteric modulators (PAMs) potentially useful for the treatment of chronic cough, urinary...
Novel caspase-2 inhibitor shows in vivo neuroprotective effects
BioWorld Science
Caspase-2-mediated cleavage of tau at Asp314 generates a neurotoxic fragment, Δtau314, that drives early synaptic dysfunction in Alzheimer’s disease (AD) and...